Mediterranean Fever (MEFV) (N-Term) Peptide
Aperçu rapide pour Mediterranean Fever (MEFV) (N-Term) Peptide (ABIN8105036)
Antigène
Source
Application
-
-
Protein Region
- N-Term
-
Fonction
- MEFV Peptide - N-terminal region
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-MEFV antibody ( ARP37973_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- MEFV (Mediterranean Fever (MEFV))
-
Sujet
-
Background Information: MEFV was identified as the gene that when mutated causes Mediterranean fever, a hereditary periodic fever syndrome. MEFV is expressed in granulocytes and myeloid bone marrow precursors. This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative Symbols: FMF, MEF, MGC126560, MGC126586, TRIM20
-
Poids moléculaire
- 86kDa
-
ID gène
- 4210
-
NCBI Accession
- NP_000234
-
UniProt
- O15553
Antigène
-